Other Meetings

FOCIS 2022 Member Society Symposium
Human Cytokine Deficiencies and Cytokinopathies

FOCIS 2022 Member Society Symposium
Human Cytokine Deficiencies and Cytokinopathies
Presented by The International Cytokine & Interferon Society
Symposium Chairs: Dusan Bogunovic, – Icahn School of Medicine at Mount Sinai and Kate Jeffrey, Moderna/Harvard University
The International Cytokine & Interferon Society (ICIS) Member Society Symposium at FOCIS 2022 will feature the newest research devoted to human cytokine deficiencies and cytokanopathies alike, both of which impact human health, provide insight into fundamental biological principles, and offer targets for therapy of rare and common diseases. [READ MORE]

Other Meetings

Global ImmunoTalks

2022 ORGANIZERS Burkhard Becher, Kate Fitzgerald, Florent Ginhoux, Matteo Iannacone, Susan Kaech and Laura Mackay Live on Wednesdays 9AM PST, 12PM EST, 4PM GMT *Please note GMT time will change to 5PM starting November 6th 2022 due to USA daylight saving time ** Talks denoted with two stars in the [READ MORE]

InflammaZoom
Other Meetings

InflammaZoom International Webinar Series on Inflammasome Signalling

This monthly webinar series has been extremely successful, setting a gold standard in quality and accessibility, with over 1500 registered users from over 300 international institutions and companies. This platform has provided an excellent opportunity for immunologists active in innate Immune research within Cambridge and internationally, to continue discussions and share findings. [READ MORE]

Other Meetings
Meeting Report

ICIS Guest Symposium at AAI Virtual Immunology 2021

Guest ICIS Symposium at virtual AAI meeting IMMUNOLOGY2021, May 13, 2021  Emerging Roles of Type III Interferons in COVID-19, Gut Microbiome, Adaptive Immunity, and Anti-Fungal Immunity  The symposium started with a brief overview of type III IFNs by Sergei Kotenko, Rutgers University. He covered discoveries leading to the identification of [READ MORE]

Meeting Report

Report on the Korean Association of Immunologists (KAI) International Meeting 2021 Hybrid, June 2-4

The Annual International Meeting of Korean Association of Immunologists (KAI 2021) was held on June 2 – 4, 2021 at the Swiss Grand Hotel in Seoul, Korea. Despite the continuing global COVID-19 pandemic and a strict social distancing policy in Korea, the on/offline hybrid meeting was highly successful with about 900 participants (181 abstracts) from 21 countries. The scientific program included 4 plenary lectures, 14 Major Symposia, 3 Satellite Symposia, 6 Workshops, 2 Education Sessions, and many Industry Symposia. The plenary lectures were given by Mi-Na Kwon (Korea), Laurence Zitvogel (France), Mark Davis (USA), and Ruslan Medzhitov (USA). More information on KAI 2021 can be found at https://kai2021.org/register/KAI2021/main.html. KAI 2022 is planned to be held on Nov. 3 – 5, 2022 at the Dragon City Hotel in Seoul, Korea.

The Korean Association of Immunologists (KAI) is the national society of immunology researchers that includes basic immunologists and clinicians. KAI started in1974 with 48 inaugural members and has grown to have more than 3,000 current members. This year KAI is sponsoring one scientific session at Cytokines 2021 on Cytokines and Bystander T Cell Activation.

[READ MORE]

Other Meetings
Other Meetings

International Cytokine & Interferon Society (ICIS) Symposium – Emerging Roles of Type III Interferons in COVID-19, Gut Microbiome, Adaptive Immunity, and Anti-Fungal Immunity

Thursday, May 13, 2021 5:00 PM ET – 7:00 PM ET

International Cytokine and Interferon Society (ICIS) Symposium
Emerging Roles of Type III Interferons in COVID-19, Gut Microbiome, Adaptive Immunity, and Anti-Fungal Immunity
Chairs:
Ludmila Prokunina-Olsson, NCI, NIH
Sergei V. Kotenko, Rutgers Univ.
Speakers:
Kristin A. Hogquist, Univ. of Minnesota, Distinct roles for type I and III interferons in thymic selection
Megan T. Baldridge, Washington Univ. Sch. of Med., Restriction of intestinal viral cellular tropism by IFN-λ
Amariliz Rivera, Rutgers Univ., Novel insights on IFN-λ in innate anti-fungal immunity
Ivan Zanoni, Harvard Med. Sch., Impact and regulation of type III interferon production in COVID-19
Ludmila Prokunina-Olsson, NCI, NIH, Type III interferon and the genetics of COVID-19 [READ MORE]